IBDEI1J5 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24459,0)
 ;;=M80.00XA^^107^1204^2
 ;;^UTILITY(U,$J,358.3,24459,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24459,1,3,0)
 ;;=3^Age-Related Osteoporosis w/ Fx,Unspec Site,Init Encntr
 ;;^UTILITY(U,$J,358.3,24459,1,4,0)
 ;;=4^M80.00XA
 ;;^UTILITY(U,$J,358.3,24459,2)
 ;;=^5013363
 ;;^UTILITY(U,$J,358.3,24460,0)
 ;;=M81.0^^107^1204^3
 ;;^UTILITY(U,$J,358.3,24460,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24460,1,3,0)
 ;;=3^Age-Related Osteoporosis w/o Fx
 ;;^UTILITY(U,$J,358.3,24460,1,4,0)
 ;;=4^M81.0
 ;;^UTILITY(U,$J,358.3,24460,2)
 ;;=^5013555
 ;;^UTILITY(U,$J,358.3,24461,0)
 ;;=M85.80^^107^1204^26
 ;;^UTILITY(U,$J,358.3,24461,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24461,1,3,0)
 ;;=3^Osteopenia,Unspec Site
 ;;^UTILITY(U,$J,358.3,24461,1,4,0)
 ;;=4^M85.80
 ;;^UTILITY(U,$J,358.3,24461,2)
 ;;=^5014473
 ;;^UTILITY(U,$J,358.3,24462,0)
 ;;=N62.^^107^1204^5
 ;;^UTILITY(U,$J,358.3,24462,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24462,1,3,0)
 ;;=3^Gynecomastia
 ;;^UTILITY(U,$J,358.3,24462,1,4,0)
 ;;=4^N62.
 ;;^UTILITY(U,$J,358.3,24462,2)
 ;;=^5015790
 ;;^UTILITY(U,$J,358.3,24463,0)
 ;;=E66.3^^107^1204^27
 ;;^UTILITY(U,$J,358.3,24463,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24463,1,3,0)
 ;;=3^Overweight
 ;;^UTILITY(U,$J,358.3,24463,1,4,0)
 ;;=4^E66.3
 ;;^UTILITY(U,$J,358.3,24463,2)
 ;;=^5002830
 ;;^UTILITY(U,$J,358.3,24464,0)
 ;;=E89.1^^107^1204^31
 ;;^UTILITY(U,$J,358.3,24464,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24464,1,3,0)
 ;;=3^Postprocedural Hypoinsulinemia
 ;;^UTILITY(U,$J,358.3,24464,1,4,0)
 ;;=4^E89.1
 ;;^UTILITY(U,$J,358.3,24464,2)
 ;;=^5003036
 ;;^UTILITY(U,$J,358.3,24465,0)
 ;;=R73.03^^107^1204^33
 ;;^UTILITY(U,$J,358.3,24465,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24465,1,3,0)
 ;;=3^Pre-Diabetes
 ;;^UTILITY(U,$J,358.3,24465,1,4,0)
 ;;=4^R73.03
 ;;^UTILITY(U,$J,358.3,24465,2)
 ;;=^8295662
 ;;^UTILITY(U,$J,358.3,24466,0)
 ;;=E73.9^^107^1204^18
 ;;^UTILITY(U,$J,358.3,24466,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24466,1,3,0)
 ;;=3^Lactose Intolerance,Unspec
 ;;^UTILITY(U,$J,358.3,24466,1,4,0)
 ;;=4^E73.9
 ;;^UTILITY(U,$J,358.3,24466,2)
 ;;=^5002914
 ;;^UTILITY(U,$J,358.3,24467,0)
 ;;=H40.9^^107^1205^11
 ;;^UTILITY(U,$J,358.3,24467,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24467,1,3,0)
 ;;=3^Glaucoma,Unspec
 ;;^UTILITY(U,$J,358.3,24467,1,4,0)
 ;;=4^H40.9
 ;;^UTILITY(U,$J,358.3,24467,2)
 ;;=^5005931
 ;;^UTILITY(U,$J,358.3,24468,0)
 ;;=H26.9^^107^1205^7
 ;;^UTILITY(U,$J,358.3,24468,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24468,1,3,0)
 ;;=3^Cataract,Unspec
 ;;^UTILITY(U,$J,358.3,24468,1,4,0)
 ;;=4^H26.9
 ;;^UTILITY(U,$J,358.3,24468,2)
 ;;=^5005363
 ;;^UTILITY(U,$J,358.3,24469,0)
 ;;=H10.9^^107^1205^10
 ;;^UTILITY(U,$J,358.3,24469,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24469,1,3,0)
 ;;=3^Conjunctivitis,Unspec
 ;;^UTILITY(U,$J,358.3,24469,1,4,0)
 ;;=4^H10.9
 ;;^UTILITY(U,$J,358.3,24469,2)
 ;;=^5004716
 ;;^UTILITY(U,$J,358.3,24470,0)
 ;;=H11.32^^107^1205^8
 ;;^UTILITY(U,$J,358.3,24470,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24470,1,3,0)
 ;;=3^Conjunctival Hemorrhage,Left Eye
 ;;^UTILITY(U,$J,358.3,24470,1,4,0)
 ;;=4^H11.32
 ;;^UTILITY(U,$J,358.3,24470,2)
 ;;=^5004783
 ;;^UTILITY(U,$J,358.3,24471,0)
 ;;=H11.31^^107^1205^9
 ;;^UTILITY(U,$J,358.3,24471,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24471,1,3,0)
 ;;=3^Conjunctival Hemorrhage,Right Eye
